Research and Breakthroughs

New research at CHLA is harnessing low-field MRI to improve the diagnosis—and treatment—of lung disease in children.

A CHLA study was the first to examine a medial pectoral nerve to axillary nerve transfer in babies with brachial plexus birth injuries.

An international expert at CHLA talks about the state of hemophilia gene therapy—and what’s on the horizon.

A CHLA team is looking deep into the intestinal lining to uncover potential new treatment targets in IBD.

Neuromuscular scoliosis curves 80 degrees or larger require more resources—and achieve less optimal results.

The research uses clinical trial data to find how often infants with neonatal hypoxic-ischemic encephalopathy have perinatal arterial ischemic strokes.

The novel approach marks a significant step forward in developing CAR T-cell therapy for acute myeloid leukemia.

Children’s Hospital Los Angeles researcher Anna Cushing, MD, collaborated on a study that found U.S. hospitals closed a third of their pediatric inpatient units between 2008 and 2022. The study is a

A clinical trial at CHLA is studying virus-specific T-cell therapy as a potential treatment for newborns with congenital cytomegalovirus.

A multi-center clinical trial demonstrates how new reporting tools help symptom management and intervention for children receiving cancer treatment.